List of conversion stocks (Part 1) [Parabolic Signal Conversion Stocks]

○List of stocks undergoing Buy conversion in the market Code Stock Name Closing Price SAR Tokyo Main Board <1301> Kiyokyo 4115 3945 <1332> Nissui 900873 <1377> Sakata Seed 34703370 <1726> Br. HD 346330 <1802> Obayashi Corporation 21012025 <1808> Haseko Corporation 20491980 <1820> Nishimatsu Construction 52485066 <1887> Japan National.

Fisco JapanDec 30, 2024 08:28

DNA, ETC [Stocks with Interest Viewed from Changes in Volume]

Closing price compared to the previous day Volume *<1483> iShares 2,896,811,217 *<162A> AI Select Daily Stock ETN 1,032,520,051,26 *<7044> Piarra 250,192,639,100 *<1474> One ETF Nikkei 26,190,695,954,7 *<2323> fonfun 884,118,107,200 *<1369> DIAM 225,405,108,501,5507 *<1625> Electronics Precision 391,106,701,466 *<234A>

Fisco JapanDec 30, 2024 07:55

List of breakout stocks (Part 1) [Ichimoku Kinko Hyo - List of breakout stocks]

○ List of stocks above the clouds in the market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Main Board <1898> Seiki Tokyu 1554 1531.25 1533.5 <2002> Nisshin Flour G 1845.1810.75 1841.5 <2117> Welneo S 2229 2226.25 2212 <2127> Japan M&A 6536 48.25 644.5 <2331> ALSOK 1089 10

Fisco JapanDec 30, 2024 07:07

Stocks that moved the day before part 1: Wizus, Makino Milling Machine, DeNA, etc.

Ticker Name <Code> Closing Price on the 27th ⇒ Change from Previous Day Okamoto Glass <7746> 258 0 Increased production capacity of Glass polarizers. Became popular temporarily but lost momentum. Wizus <9696> 2420 +220 Reported that a shareholder investment fund proposed privatization. Ateam <3662> 1001 +33 Subsidiary of WCA, which handles web marketing consulting and web marketing operations. KTK <3035> 555 -19 Progress in operating profit for the first quarter versus full-year Financial Estimates.

Fisco JapanDec 28, 2024 06:15

DNA, Withus, E-Store, etc.

<3321> Mitachi 1178 -52 significantly continued to decline. The previous day, the first half earnings report was announced, with an operating profit of 0.95 billion yen, a year-on-year increase of 1.3%. On November 22, the forecast was revised upward from the previous estimate of 0.6 billion yen to 0.9 billion yen, landing as expected. The full-year estimates were also revised upward at the same time, from the previous 1.8 billion yen to 1.9 billion yen, a 19.4% increase compared to the previous period, but this time the forecast has been held steady. While the stock price was trading at a high level, it responded to the earnings report which lacked surprises.

Fisco JapanDec 27, 2024 15:18

Research drugs, ETC, continue to be ranked, with a licensing agreement related to Johnson & Johnson and STAT6 inhibitors.

Research pharmaceutical company <4521> has ranked (as of 14:32). It has seen significant continued growth. After the previous day's Trading ended, the company announced that it has signed a contract granting an exclusive license to Johnson & Johnson for the global development, manufacturing, and commercialization of the 'STAT6 Program' that is being developed as a next-generation oral treatment for type 2 inflammatory diseases (such as atopic dermatitis and asthma). It will receive a one-time contract payment of 30 million USD during the fiscal year ending March 2025.

Fisco JapanDec 27, 2024 13:33